Biotechnology and Medical Research (TRBC)

Scientists create safer pig organs with goal of transplants for humans

Scientists create safer pig organs with goal of transplants for humans

Published 11/08/2017

Scientists at a Massachusetts company seeking to make pig organs safe enough to be transplanted into humans have used gene-editing technology to clone piglets that lack a potentially dangerous retrovirus, according to a study released on Thursday. [more…]

Vernalis hit by fresh U.S. setback for cough and cold drug

Vernalis hit by fresh U.S. setback for cough and cold drug

Published 07/08/2017

Shares in Vernalis fell more than 15 percent on Monday as the British biotech company backed by fund manager Neil Woodford and his previous employer Invesco announced a fresh setback for a key new drug in the United States. [more…]

DEA proposes cutting production of some opioid painkillers

DEA proposes cutting production of some opioid painkillers

Published 04/08/2017

The U.S. Drug Enforcement Administration (DEA) on Friday proposed a 20 percent reduction in the manufacture of certain commonly prescribed opioid painkillers as well as other controlled substances for next year. [more…]

U.S. taxable bond funds attract cash for fourth straight week: Lipper

U.S. taxable bond funds attract cash for fourth straight week: Lipper

Published 04/08/2017

Investors poured $1.8 billion into U.S.-based taxable bond funds during the latest , marking the fourth straight week of inflows into the funds, Lipper data showed on Thursday. [more…]

U.S. scientists able to alter genes of human embryos

U.S. scientists able to alter genes of human embryos

Published 02/08/2017

By Deena BeasleyU.S. scientists have succeeded in altering the genes of a human embryo to correct a disease-causing mutation, making it possible to p [more…]

Express Scripts to cover Mylan`s EpiPen, exclude rivals

Express Scripts to cover Mylan`s EpiPen, exclude rivals

Published 31/07/2017

EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.

Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.

[more…]

U.S. fund investors shun stocks during second-quarter earnings, buy bonds: Lipper

Published 27/07/2017

U.S. fund investors sidestepped stocks in favor of bonds during the latest week, Lipper data showed on Thursday, showing little confidence as a heavy dose of second-quarter corporate earnings results rolled in.

[more…]

Scientists find sunscreen potential in Antarctic plants

Scientists find sunscreen potential in Antarctic plants

Published 27/07/2017

Doctor Gustavo Zuniga holds up an Antarctic plant that has molecules that filter the solar radiation and could be used to prevent human DNA damage in Santiago, Chile July 25, 2017.

Scientists in Chile have discovered molecules in two species of Antarctic flowers that protect the plants from solar radiation and could potentially be used in products such as sunscreen for humans and protection for vulnerable crops.

[more…]

Eaton Vance fund managers see major upside for healthcare stocks: Barron`s

Eaton Vance fund managers see major upside for healthcare stocks: Barron`s

Published 16/07/2017

The portfolio managers of the $1.2 billion Eaton Vance Worldwide Health Sciences fund are expecting big gains from a trio of healthcare stocks.

[more…]

Morphosys sees revenue boost from Janssen psoriasis drug

Morphosys sees revenue boost from Janssen psoriasis drug

Published 14/07/2017

German biotech group Morphosys expects to receive royalties from psoriasis drug guselkumab for five months this year, its Chief Executive Simon Moroney said, after its licensee received U.S. regulatory approval.

[more…]